BioScrip, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against BioScrip, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of November 29, 2013
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased BioScrip, Inc. (“BioScrip” or the “Company”) (NasdaqGS:BIOS) common stock between August 8, 2011 and September 20, 2013.
For more information, click here: http://zlk.9nl.com/bioscrip-bios/.
The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or omitted materially adverse facts about the Company’s business, operations and prospects. In particular, it is alleged that the Company violated the False Claims Act and other federal and state statutes by improperly distributing the Novartis Pharmaceuticals Corporation product Exjade through its specialty pharmacy operations.
On September 23, 2013, the Company acknowledged the receipt of a civil investigate demand issued by the US Attorney’s Office for the Southern District of New York and the receipt of a subpoena from the New York State Attorney General’s Medicaid Fraud Control Unit. Upon this news, shares of BioScrip fell more than 23 percent.If you suffered a loss in BioScrip you have until November 29, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/bioscrip-bios/. Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV